Biora Therapeutics(BIOR) - 2023 Q3 - Quarterly Report

Biora Therapeutics, Inc. (Exact name of registrant as specified in its charter) UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q or ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Commission File Number: 001-39334 Delaware 27-3950390 (State or other jurisdiction of incorporation or organization) (I.R.S. Employer Identification No.) 4330 La Jolla Village Drive, Suite 300, San Diego, CA 92122 Registrant's telephone number, including a ...